Sutro Biopharma, Inc.
STRO
$0.859
-$0.0436-4.83%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -227.46M | -123.95M | -124.45M | -114.96M | -106.79M |
| Total Depreciation and Amortization | 7.22M | 7.08M | 7.02M | 6.96M | 6.82M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.80M | 8.09M | 28.80M | 19.21M | 22.74M |
| Change in Net Operating Assets | 8.90M | 3.05M | 13.92M | -26.58M | -34.38M |
| Cash from Operations | -191.54M | -105.73M | -74.72M | -115.37M | -111.62M |
| Capital Expenditure | -3.10M | -3.47M | -2.97M | -3.82M | -4.32M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 221.61M | 110.98M | -150.83M | -3.45M | 391.00K |
| Cash from Investing | 218.51M | 107.51M | -153.80M | -7.27M | -3.92M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.08M | -7.21M | -10.33M | -13.46M | -12.50M |
| Issuance of Common Stock | 98.65M | 98.65M | 98.51M | 3.03M | 14.34M |
| Repurchase of Common Stock | -509.00K | -485.00K | -444.00K | -413.00K | -490.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -3.54M | 136.21M | 136.21M |
| Cash from Financing | 94.05M | 90.95M | 84.20M | 125.37M | 137.55M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 121.02M | 92.73M | -144.32M | 2.73M | 22.01M |